Aaron Rosenberg
General Practice · Mequon, WINPI 1306237417
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,475 of the $20,813 with a category attached, or 64.7%. AbbVie accounts for 82.9% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2020 at $5,643 and has fallen 90.1% since, to $559 in 2025. Among general practice clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 264 payments — averaging $78.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$17K
- Gilead$899
- Lilly USA, LLC$570
- Orexo US, Inc.$440
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$259
- Indivior Inc.$202
- plus $1K from 20 others
What the payments were for
- Speaking & faculty fees$13,47565%
- Travel & lodging$2,42912%
- Food & beverage$4,85323%
- Education$550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 87 | $17,256 |
| Gilead | 46 | $899 |
| Lilly USA, LLC | 32 | $570 |
| Orexo US, Inc. | 22 | $440 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $259 |
| Indivior Inc. | 8 | $202 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $193 |
| Corium, LLC | 4 | $185 |
| Alkermes, Inc. | 9 | $162 |
| Otsuka America Pharmaceutical, Inc. | 6 | $129 |
| USWM, LLC | 4 | $73 |
| Lundbeck LLC | 3 | $63 |
| Biodelivery Sciences International, Inc. | 3 | $50 |
| Braeburn Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Amarin Pharma, Inc. | 1 | $30 |
| Pfizer | 1 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Biogen | 1 | $22 |
| Heartflow, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Shionogi Inc | 1 | $18 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,813 in reported general payments places this provider in the 95th percentile of 1,554 general practice providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $13,477 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $9,731 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 51 | $9,282 |
| Adzenys Xr-OdtAmphetamine | 11 | $5,388 |
| Divalproex Sodium | 14 | $1,338 |
| Haloperidol | 14 | $1,086 |
| Gabapentin | 27 | $623 |
| Tizanidine Hcl | 28 | $383 |
| Fluoxetine Hcl | 22 | $358 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $299 |
| Metformin Hcl | 17 | $288 |
| Levetiracetam | 14 | $271 |
| Omeprazole | 15 | $267 |
| Methylphenidate Hcl | 11 | $261 |
| Amlodipine Besylate | 50 | $239 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $30 | $13,47723 claims |
| Indivior Inc.Suboxone | $202 | $9,73114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,554 general practice providers in Wisconsin.
Other general practice in Mequon
- Julie Melbinger-WagnerMequon$7K
- Michael RomeneskoAppleton$457K
- Brian JenkinsNeenah$93K
- Michael SzymanskiMenomonee Falls$71K
- Jessica KeldermanMadison$59K
- James AmstadtSun Prairie$49K
- Amanda ReiswigMilwaukee$46K
- Mary EldridgeKenosha$44K
- David Fergusonde Pere$43K
- Tamara BaileySchofield$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.